Legend Biotech
robust pipeline of the next generation cell therapies fens | Legend Biotech
Company
Deck Type
IPO
Sector
Industry
Deck date
May 2020
Slide
8 of 42
Related slides by other companies
Nuscale
Results
May 2023
robust and diversified global customer pipeline | Nuscale
AstraZeneca
Investor Conference
January 2024
strong business development momentum through | AstraZeneca
Nuscale
SPAC
December 2021
robust and diversified global customer pipeline seg | Nuscale
Advent
SPAC
January 2021
next generation technology transition battery fuel cell | Advent
Other recent decks by Legend Biotech
See all presentations (6 decks)
Investor Presentation
April 2025
Results
November 2024
Investor Presentation
January 2024
Results
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights